Celldex Therapeutics (NASDAQ:CLDX) Receives New Coverage from Analysts at TD Cowen
TD Cowen started coverage on shares of Celldex Therapeutics (NASDAQ:CLDX – Free Report) in a research note issued to investors on Wednesday morning, Marketbeat reports. The firm issued an outperform rating on the biopharmaceutical company’s stock. Several other analysts have also recently weighed in on CLDX. HC Wainwright raised their price objective on shares of […]
More Stories
WisdomTree U.S. High Yield Corporate Bond Fund Declares Dividend of $0.24 (NYSEARCA:QHY)
WisdomTree U.S. High Yield Corporate Bond Fund (NYSEARCA:QHY – Get Free Report) announced a dividend on Friday, November 22nd,NASDAQ Dividends...
FT Vest SMID Rising Dividend Ac (NYSEARCA:SDVD) Announces Dividend of $0.14
FT Vest SMID Rising Dividend Ac (NYSEARCA:SDVD – Get Free Report) announced a dividend on Friday, November 22nd,NASDAQ Dividends reports....
Airports of Thailand Public Company Limited (OTCMKTS:AIPUY) Plans Dividend Increase – $0.16 Per Share
Airports of Thailand Public Company Limited (OTCMKTS:AIPUY – Get Free Report) announced a dividend on Saturday, November 23rd,NASDAQ Dividends reports....
Corning Natural Gas (OTCMKTS:CNIG) vs. Centuri (NYSE:CTRI) Financial Comparison
Centuri (NYSE:CTRI – Get Free Report) and Corning Natural Gas (OTCMKTS:CNIG – Get Free Report) are both utilities companies, but...
Critical Analysis: Lucas GC (NASDAQ:LGCL) versus Sangoma Technologies (NASDAQ:SANG)
Institutional & Insider Ownership 39.7% of Sangoma Technologies shares are owned by institutional investors. 14.0% of Sangoma Technologies shares are...
Americans Need $5.3 Million Net Worth to Be Considered Financially Successful: Survey
By Naveen Athrappully Americans have high expectations of what it means to be financially successful but many of them do...